In addition, MACC1-AS1 was found to be highly expressed in stage II, III, and IV pancreatic cancer patients, especially in advanced stage (stage IV) patients, with statistically significant differences in pairwise comparisons (P < 0.05) (Fig. 1B). This evidence concerns the gene MACC1 and pancreatic neoplasm.